#USA #HWP Group #Market Access #Upper Saddle River #GMAS

The HWP Group Expands Its Reach with GMAS Acquisition

The HWP Group (HWP), a prominent player in medical communications and strategic consulting for the life sciences sector, has recently made headlines with its acquisition of Global Market Access Solutions (GMAS), a well-respected consultancy focusing on market access and health economics on a global scale. This bold move marks a significant stepping stone in HWP's ongoing growth and development strategy.

With this acquisition, HWP is poised to significantly enhance its service offerings. The integration of GMAS brings valuable expertise in various critical areas including market access strategy, health economics and outcomes research (HEOR), pricing and payer insights, evidence synthesis, and lifecycle value strategy. This expanded capacity uniquely positions the combined entity to effectively support clients throughout the entire product lifecycle—from early clinical development, through product launch, reimbursement, and ultimately ensuring sustained patient access.

In the current healthcare landscape, characterized by resource limitations, effective market access strategies and robust health economic assessments are more crucial than ever. As payers and health systems increasingly demand comprehensive clinical and economic data to substantiate reimbursement and funding decisions, GMAS stands out for its deep knowledge in articulating the economic advantages of both new and existing medical innovations. By employing a variety of economic evaluation frameworks, GMAS not only aids in the delivery of effective healthcare services but also plays a pivotal role in ensuring long-term commercial success for its clients.

Jani Hegarty, the Chief Executive Officer and Founder of The HWP Group, expressed excitement about this development, stating, “We are taking a decisive step forward in our mission to support our clients in bridging the gap between scientific innovation and real-world patient access. Market access and health economics have shifted from being optional considerations to foundational elements in healthcare strategy. Integrating GMAS’s capabilities will empower us to help our clients not just craft compelling scientific narratives but also demonstrate economic value to payers and healthcare systems, thereby ensuring faster and broader patient access.”

Mark Connolly, PhD, the Managing Partner at GMAS, shared his enthusiasm about the transition as well, saying, “Nikos Kotsopoulos and I are excited to join The HWP Group, where we can enhance our endeavor to improve patient access to necessary medications. This change will allow us to expand our market access and HEOR knowledge within a platform that shares our passion for rigor, strategy, and partnership. We are uniquely positioned to assist life sciences firms in ensuring their innovations achieve not only regulatory approval but also reimbursement and accessibility.”

Luis Gonzalez, Senior Partner at NMS Capital, commented on the significance of this acquisition in stating, “From the very beginning of our partnership with HWP, we believed in their vision to create a differentiated and integrated service platform for the life sciences sector. Adding GMAS to the fold is a natural trajectory that introduces critical market access and HEOR capabilities necessary for achieving commercial success in today’s healthcare environment. We are proud to continue this journey with HWP and are eager to see the benefits this amalgamation will yield for both clients and patients.”

This acquisition further solidifies HWP’s standing as a holistic strategic partner for pharmaceutical and biotechnology firms navigating the complexities of global markets. In a climate where clinical excellence must align with compelling economic evidence, HWP is taking significant steps to ensure that its clients can successfully achieve reimbursement, market adoption, and a meaningful impact on patient health.

For more details, you can visit thehwpgroup.com.